Mutual Fund Ownership
Ownership as on: Tue, 23 Jul, 2024

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)12.48
% of AUM4.05%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)37.56
% of AUM3.96%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.42
% of AUM3.89%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)24.85
% of AUM3.48%

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

NA
Equity
Amount Invested (Cr.)141.16
% of AUM3.42%

FAQs about Alkem Laboratories share price

Alkem Laboratories is trading at 5195.60 as on Tue Jul 23 2024 09:59:15. This is -0.31% lower as compared to its previous closing price of 5211.70.

The market capitalization of Alkem Laboratories is 62113.40 Cr as on Tue Jul 23 2024 09:59:15.

The average broker rating on Alkem Laboratories is Hold. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 6 analysts have given a hold rating
  • 3 analysts have given a sell rating
  • 3 analysts have given a strong sell rating

The 52 wk high for Alkem Laboratories is 5581.20 whereas the 52 wk low is 3440.05

Alkem Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 32.90
  • Sector P/E: 31.07
  • Dividend Yield: 0.77%
  • D/E ratio: 0.14

Alkem Laboratories reported a net profit of 1795.77 Cr in 2024.

Recommended For You
Trending Stocks
3,468.15+215.55(6.63%)
492.05+25.75(5.52%)
382.35+8.80(2.36%)
3,538.40-113.05 (-3.10%)
6,732.20-150.00 (-2.18%)
HomeMarketsPremiumInstant LoanBudget